Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
CVS Health is raising its guidance for the year as it blew past Wall Street analysts' expectations in the second quarter. | CVS Health is raising its guidance for the year as it blew past Wall Street analysts' expectations in the second quarter.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

All of the health-care giant's business segments, including its insurer Aetna, its retail pharmacy and health services unit,…

CVS also announced a new collaboration with Eli Lilly that will make Zepbound and Foundayo accessible to eligible patients on the…

The third-quarter results mark David Joyner's first full year as CEO of CVS, which had struggled to drive higher profits and…

CVS CEO David Joyner pointed to strength in its retail pharmacy and improvement in its insurance unit, Aetna, which is grappling…

CVS beat Wall Street expectations by a wide margin in the second quarter and raised its full-year profit forecast to as much as…

The results signal steady progress in the health-care giant's aggressive turnaround plan under CEO David Joyner, who stepped into…

CVS Health Stock Is Falling Wednesday: What's Going On? - CVS Health (NYSE:CVS)